Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research

Abstract Objective The benefit of adjuvant chemotherapy is still controversial for stage II gastric cancer patients. This study aims to identify prognostic factors to guide individualized treatment for stage II gastric cancer patients. Methods We retrospectively reviewed 1121 stage II gastric cancer...

Full description

Bibliographic Details
Main Authors: Zi-Jian Deng, Run-Cong Nie, Jun Lu, Xi-Jie Chen, Jun Xiang, Chang-Ming Huang, Ying-Bo Chen, Jun-Sheng Peng, Shi Chen
Format: Article
Language:English
Published: BMC 2021-10-01
Series:BMC Gastroenterology
Subjects:
Online Access:https://doi.org/10.1186/s12876-021-01937-9
_version_ 1818730623775277056
author Zi-Jian Deng
Run-Cong Nie
Jun Lu
Xi-Jie Chen
Jun Xiang
Chang-Ming Huang
Ying-Bo Chen
Jun-Sheng Peng
Shi Chen
author_facet Zi-Jian Deng
Run-Cong Nie
Jun Lu
Xi-Jie Chen
Jun Xiang
Chang-Ming Huang
Ying-Bo Chen
Jun-Sheng Peng
Shi Chen
author_sort Zi-Jian Deng
collection DOAJ
description Abstract Objective The benefit of adjuvant chemotherapy is still controversial for stage II gastric cancer patients. This study aims to identify prognostic factors to guide individualized treatment for stage II gastric cancer patients. Methods We retrospectively reviewed 1121 stage II gastric cancer patients who underwent D2 radical gastrectomy from 2007 to 2017 in the Sixth Affiliated Hospital of Sun Yat-sen University, FuJian Medical School Affiliated Union Hospital and Sun Yat-sen University Cancer Center. Propensity score matching was used to ensure that the baseline data were balanced between the adjuvant chemotherapy group and surgery-only group. Kaplan–Meier survival and multivariate Cox regression analyses were carried out to identify independent prognostic factors. Results In univariate analysis, after propensity score matching, age, tumor location, tumor size, CEA, T stage and N stage were associated with overall survival (OS). Multivariate analysis illustrated that age ≥ 60 years old, linitis plastica and T4 were independent risk factors for OS, but lower location and adjuvant chemotherapy were protective factors. Conclusion Stage II gastric cancer patients with adverse prognostic factors (age ≥ 60, linitis plastica and T4) have poor prognosis. Adjuvant chemotherapy may be more beneficial for these patients.
first_indexed 2024-12-17T23:04:44Z
format Article
id doaj.art-ac6b752abd65436588110d597ade8fab
institution Directory Open Access Journal
issn 1471-230X
language English
last_indexed 2024-12-17T23:04:44Z
publishDate 2021-10-01
publisher BMC
record_format Article
series BMC Gastroenterology
spelling doaj.art-ac6b752abd65436588110d597ade8fab2022-12-21T21:29:19ZengBMCBMC Gastroenterology1471-230X2021-10-012111910.1186/s12876-021-01937-9Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based researchZi-Jian Deng0Run-Cong Nie1Jun Lu2Xi-Jie Chen3Jun Xiang4Chang-Ming Huang5Ying-Bo Chen6Jun-Sheng Peng7Shi Chen8Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-Sen UniversityDepartment of Gastric Surgery, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineDepartment of Gastric Surgery, Fujian Medical University Union HospitalGuangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-Sen UniversityGuangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-Sen UniversityDepartment of Gastric Surgery, Fujian Medical University Union HospitalDepartment of Gastric Surgery, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineGuangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-Sen UniversityGuangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-Sen UniversityAbstract Objective The benefit of adjuvant chemotherapy is still controversial for stage II gastric cancer patients. This study aims to identify prognostic factors to guide individualized treatment for stage II gastric cancer patients. Methods We retrospectively reviewed 1121 stage II gastric cancer patients who underwent D2 radical gastrectomy from 2007 to 2017 in the Sixth Affiliated Hospital of Sun Yat-sen University, FuJian Medical School Affiliated Union Hospital and Sun Yat-sen University Cancer Center. Propensity score matching was used to ensure that the baseline data were balanced between the adjuvant chemotherapy group and surgery-only group. Kaplan–Meier survival and multivariate Cox regression analyses were carried out to identify independent prognostic factors. Results In univariate analysis, after propensity score matching, age, tumor location, tumor size, CEA, T stage and N stage were associated with overall survival (OS). Multivariate analysis illustrated that age ≥ 60 years old, linitis plastica and T4 were independent risk factors for OS, but lower location and adjuvant chemotherapy were protective factors. Conclusion Stage II gastric cancer patients with adverse prognostic factors (age ≥ 60, linitis plastica and T4) have poor prognosis. Adjuvant chemotherapy may be more beneficial for these patients.https://doi.org/10.1186/s12876-021-01937-9Gastric cancerStage IIPrognosisAdjuvant chemotherapyPropensity score matching
spellingShingle Zi-Jian Deng
Run-Cong Nie
Jun Lu
Xi-Jie Chen
Jun Xiang
Chang-Ming Huang
Ying-Bo Chen
Jun-Sheng Peng
Shi Chen
Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research
BMC Gastroenterology
Gastric cancer
Stage II
Prognosis
Adjuvant chemotherapy
Propensity score matching
title Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research
title_full Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research
title_fullStr Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research
title_full_unstemmed Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research
title_short Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research
title_sort survival analysis of stage ii gastric cancer patients after d2 gastrectomy a chinese people based research
topic Gastric cancer
Stage II
Prognosis
Adjuvant chemotherapy
Propensity score matching
url https://doi.org/10.1186/s12876-021-01937-9
work_keys_str_mv AT zijiandeng survivalanalysisofstageiigastriccancerpatientsafterd2gastrectomyachinesepeoplebasedresearch
AT runcongnie survivalanalysisofstageiigastriccancerpatientsafterd2gastrectomyachinesepeoplebasedresearch
AT junlu survivalanalysisofstageiigastriccancerpatientsafterd2gastrectomyachinesepeoplebasedresearch
AT xijiechen survivalanalysisofstageiigastriccancerpatientsafterd2gastrectomyachinesepeoplebasedresearch
AT junxiang survivalanalysisofstageiigastriccancerpatientsafterd2gastrectomyachinesepeoplebasedresearch
AT changminghuang survivalanalysisofstageiigastriccancerpatientsafterd2gastrectomyachinesepeoplebasedresearch
AT yingbochen survivalanalysisofstageiigastriccancerpatientsafterd2gastrectomyachinesepeoplebasedresearch
AT junshengpeng survivalanalysisofstageiigastriccancerpatientsafterd2gastrectomyachinesepeoplebasedresearch
AT shichen survivalanalysisofstageiigastriccancerpatientsafterd2gastrectomyachinesepeoplebasedresearch